COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...

May 13 (Reuters) - Medical device maker Kensey Nash Corp agreed to sell its endovascular business to single-use medical device maker Spectranetics Corp for $24 million, including possible milestone ...

COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced receipt of U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) of the Stellarex™ drug-coated balloon (DCB), ...

According to a recent press release, Colorado Springs-based Spectranetics announced that it has received FDA 510(k) clearance for its Turbo-Power™ Laser Atherectomy Catheter, a peripheral atherectomy ...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced it has entered into a definitive agreement to acquire the endovascular business of Kensey Nash ...

DENVER--(BUSINESS WIRE)--HEART RHYTHM 2010 – Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society ...

Things could have gone badly for Stellarex. The proprietary drug-coated balloon technology, used to deliver medication to narrowed blood vessels in the legs, was sold for the fire-sale price of $30 ...

Spectranetics recalled more than 1,900 Bridge Occlusion Balloon Catheters due to a product flaw that may prevent the device from working properly. Here are five things to know. 1. Some recalled ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of ...

According to a June 28, 2017 press release, Dutch healthcare company Philips has agreed to buy Colorado Springs-based Spectranetics Corporation, a cardiac device manufacturer, for approximately 1.9 ...

COLORADO SPRINGS — Things didn’t look so great for Spectranetics in 2010. That was when former CEO John Schulte and three others were indicted on 12 federal counts of conspiracy to defraud the federal ...